These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7513194)

  • 1. MRL-lpr/lpr disease: theories meet Fas.
    Steinberg AD
    Semin Immunol; 1994 Feb; 6(1):55-69. PubMed ID: 7513194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
    Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
    J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
    Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
    J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Existence of a small population of IL-2R beta hi TCRint cells in SCG and MRL-lpr/lpr mice which produce normal Fas mRNA and Fas molecules from the lpr gene.
    Yamagiwa S; Kuwano Y; Hasegawa K; Sato K; Ohtsuka K; Iiai T; Tomiyama K; Watanabe H; Sugahara S; Seki S; Asakura H; Abo T
    Eur J Immunol; 1996 Jul; 26(7):1409-16. PubMed ID: 8766540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of the protein kinase C-dependent apoptosis pathway in distinct subsets of T lymphocytes in MRL-lpr/lpr mice.
    Ohkusu K; Isobe K; Hidaka H; Nakashima I
    Eur J Immunol; 1995 Nov; 25(11):3180-6. PubMed ID: 7489761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes.
    Giese T; Davidson WF
    J Immunol; 1995 May; 154(10):4986-95. PubMed ID: 7537297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional expression of Fas (CD95) protein in autoimmune lpr mice.
    Cui H; Ju ST; Sherr DH
    Cell Immunol; 1996 Nov; 174(1):35-41. PubMed ID: 8929452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the T cell receptor repertoire in lpr mice.
    Rozzo SJ; Eisenberg RA; Cohen PL; Kotzin BL
    Semin Immunol; 1994 Feb; 6(1):19-26. PubMed ID: 8167303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gld/gld mice are unable to express a functional ligand for Fas.
    Ramsdell F; Seaman MS; Miller RE; Tough TW; Alderson MR; Lynch DH
    Eur J Immunol; 1994 Apr; 24(4):928-33. PubMed ID: 7512035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proliferative in vivo activities of lpr double-negative T cells and the primary role of p59fyn in their activation and expansion.
    Balomenos D; Rumold R; Theofilopoulos AN
    J Immunol; 1997 Sep; 159(5):2265-73. PubMed ID: 9278315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of the T cell receptor repertoire in Lpr mice.
    Herron LR; Eisenberg RA; Roper E; Kakkanaiah VN; Cohen PL; Kotzin BL
    J Immunol; 1993 Oct; 151(7):3450-9. PubMed ID: 8376785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective clonal deletion and anergy induction in TCR transgenic lpr/lpr mice.
    Mountz JD; Bluethmann H; Zhou T; Wu J
    Semin Immunol; 1994 Feb; 6(1):27-37. PubMed ID: 8167304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific intercellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice.
    Gillette-Ferguson I; Sidman CL
    Eur J Immunol; 1994 May; 24(5):1181-5. PubMed ID: 8181528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel immunoregulatory B cell pathways revealed by lpr-+ mixed chimeras.
    Sobel ES; Kakkanaiah VN; Schiffenbauer J; Reap EA; Cohen PL; Eisenberg RA
    J Immunol; 1998 Feb; 160(3):1497-503. PubMed ID: 9570572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expansion of a CD4+ T cell population bearing a distinctive beta chain in MRL lpr/lpr mice suggests a role for the fas protein in peripheral T cell selection.
    Musette P; Pannetier C; Gachelin G; Kourilsky P
    Eur J Immunol; 1994 Nov; 24(11):2761-6. PubMed ID: 7525303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.
    Ettinger R; Wang JK; Bossu P; Papas K; Sidman CL; Abbas AK; Marshak-Rothstein A
    J Immunol; 1994 Feb; 152(4):1557-68. PubMed ID: 8120369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor.
    Landolfi MM; Van Houten N; Russell JQ; Scollay R; Parnes JR; Budd RC
    J Immunol; 1993 Jul; 151(2):1086-96. PubMed ID: 7687614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the Fas antigen gene in lpr mice.
    Nagata S
    Semin Immunol; 1994 Feb; 6(1):3-8. PubMed ID: 7513193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas system-mediated apoptosis suppresses lymphopoiesis.
    Yasutomo K; Nagasawa H; Hisaeda H; Good RA; Kuroda Y; Himeno K
    J Immunol; 1996 Sep; 157(5):1981-6. PubMed ID: 8757318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.